- Home
- SI
as 11-21-2025 2:42pm EST
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | HOLLAND |
| Market Cap: | 248.2M | IPO Year: | 2025 |
| Target Price: | $19.60 | AVG Volume (30 days): | 77.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -10.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $10.92 - $17.94 | Next Earning Date: | 11-11-2025 |
| Revenue: | $41,626,000 | Revenue Growth: | 115.97% |
| Revenue Growth (this year): | 40.62% | Revenue Growth (next year): | 33.40% |
Latest Shoulder Innovations Inc. Common Stock News
SI Breaking Stock News: Dive into SI Ticker-Specific Updates for Smart Investing
PR Newswire
2 days ago
Shoulder Innovations to Participate in the Piper Sandler 37th Annual Healthcare Conference
Motley Fool
10 days ago
Why Shoulder Innovations Stock Is Skyrocketing Today
MT Newswires
10 days ago
Top Premarket Gainers
MT Newswires
10 days ago
Shoulder Innovations Reports Q3 Net Loss, Revenue Beat; Shares Gain After Hours
PR Newswire
10 days ago
Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance
Investing.com
15 days ago
A-Mark reports Q1 loss; announces acquisition, name and listing change
PR Newswire
17 days ago
Shoulder Innovations to Participate in the Jefferies Global Healthcare Conference
Investing.com
a month ago
Gold and silver miners tumble as precious metals retreat from record highs
Compare SI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SI Shoulder Innovations Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.